No Data
No Data
All You Need to Know About Cardiff Oncology (CRDF) Rating Upgrade to Buy
Cardiff Oncology Full Year 2024 Earnings: Beats Expectations
H.C. Wainwright Initiates Cardiff Oncology(CRDF.US) With Buy Rating, Announces Target Price $17
Piper Sandler Maintains Cardiff Oncology(CRDF.US) With Buy Rating, Maintains Target Price $10
Cardiff Oncology's Earnings Call: Optimism Amid Challenges
$CRDF Stock Is up 9% Today. Here's What We See in Our Data.